3W. A. Craig. Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA[J] 1995,European Journal of Clinical Microbiology & Infectious Diseases(7):636～642
4Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted disease treatment guidelines, 9010. MMWR Recomm Rep, 2010, 59 (RR-12): 1- 110.
5Parkes R, Renton A, Meheus A, et al. Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS, 2004, 15(2): 73-88.
6Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials, 1996, 17( 1 ): 1-12.
7Moorlhy TT, Lee CT, Lira KB, et al. Ceflriaxone for treatment of primary syphilis in men: a preliminary sludy. Sex Transm Dis, 1987, 14(2): 116-118.
8Sch6fer H, Vogt H J, Milbradt R. Ceftriaxone for the treatment of primary and secondary syphilis. Chemotherapy 1989, 35 (2): 140-145.
9Spornraft-Ragalter P, Abraham S, lJueck C, et al. Response of HIV-infeeted patients with syphilis to therapy with penicillin or intravenous ceftriaxone. Eur J Med Res, 2011, 16( 2 ): 47-51.
10Psomas KC, Brim M, Causse A, et al. Efficacy of ceftriaxone and doxycycline in the treatment of early syphilis. Med Mal Infect, 2012, 42(1): 15-19.
